Canaccord Genuity upgrades Olaplex stock to Buy on brand reinvigoration

Olaplex (OLPX) reported mixed Q2 2025 financial results, with revenue of $106.3 million surpassing analyst expectations and marking its first year-over-year growth in nine quarters, yet earnings per share significantly missed forecasts at -$0.0048. In response to these results, Canaccord Genuity lowered its price target for OLPX from $2.00 to $1.50 and maintained a "Hold" rating, citing margin pressure despite the revenue beat. The company, currently trading at $1.40, maintains high gross profit margins and strong free cash flow, though it has experienced past revenue volatility.

Analysis

Olaplex (OLPX) presents a mixed financial profile following its second-quarter 2025 results, signaling a potential inflection point in its turnaround efforts. The company achieved a notable revenue of $106.3 million, surpassing analyst expectations by 5.6% and marking a 2.3% year-over-year increase—its first positive top-line growth in nine quarters. This sales stabilization suggests that investments in marketing and brand reinvigoration may be gaining traction. However, this positive development was significantly undermined by severe profitability challenges, with earnings per share coming in at -$0.0048, a stark miss against the forecasted $0.0128. This discrepancy is attributed to the normalization of adjusted EBITDA margins from historical highs above 60% to a more industry-standard low-20% range. In response to these results, Canaccord Genuity lowered its price target to $1.50 while maintaining a "Hold" rating, citing the evident margin pressure. Despite the earnings miss, the company's fundamentals exhibit underlying strengths, including an impressive 71% gross profit margin and a strong free cash flow yield, indicating operational efficiency remains intact amid the revenue and profit volatility.

Key Decisions for Investors

• Investors should weigh the positive signal of a return to revenue growth against the significant negative of a substantial EPS miss, as the key question is whether margin compression is a temporary or persistent issue.
• Monitor future earnings reports closely for evidence that adjusted EBITDA margins are stabilizing in the low-20% range and that top-line momentum can be sustained into fiscal year 2025.
• Given the "Hold" rating from Canaccord Genuity and the conflicting financial signals, the stock should be viewed as a speculative turnaround play where potential valuation upside is balanced by the clear risk of continued profitability challenges.